Pete Olson

Executive Officer at Iambic Therapeutics.

Earliest Form D on file: Apr 2026

Filed Apr 8, 2026

Iambic Therapeutics

AI drug design with automated synthesis and testing

Biotech, San Diego CA

Named, Executive Officer.

$27.8M

sold of $50M offered

Network

At Iambic Therapeutics

11 people

Thomas Miller
Executive Officer, Director, signed as Chief Executive Officer
Fred Manby
Executive Officer, Director
Evan Rachlin
Director
Jishnu Bhattacharjee
Director
Kurt von Emster
Director
Mary Tagliaferri
Director

5 more at Iambic Therapeutics